|
시장보고서
상품코드
2058295
천연 바이오소재 시장 : 제품 유형별, 용도별, 지역별Natural Biomaterials Market, By Product Type, By Application, By Geography |
||||||
천연 바이오소재 시장은 2026년에 867억 달러로 추정되며, 2033년까지 1,033억 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 4.8%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 867억 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간 CAGR: | 4.80% | 2033년 시장 규모 예측: | 1,033억 달러 |
바이오소재는 생물의 조직, 장기 또는 기능을 강화, 대체 또는 치료하기 위해 사용되는 비의약품 재료로 간주됩니다. 바이오소재의 정의는 생체 조직이나 장기의 기능을 대체하거나 강화하기 위해 생체 내에 이식하기에 적합한 비의약품 물질로 재정의되었습니다. 이러한 물질은 합성 또는 천연, 비생물학적 또는 생물학적 유래의 것이며, 생체 시스템과 상호작용하는 여러 성분으로 구성되어 있습니다. 이것들은 생물의 생체 조직 대신 사용할 수 있습니다.
시장 역학
정밀 의학 및 분자 생물학 연구 개발에 대한 투자 증가가 시장 확장의 주요 요인으로 작용하고 있습니다. 다양한 만성 질환에 걸리기 쉬운 고령 인구의 증가 또한 천연 바이오소재 수요를 촉진하는 요인 중 하나입니다. 약물전달 기기, 성형외과, 조직공학, 기타 의료용 임플란트 등 다양한 첨단 의료 기술 분야에서 바이오소재 과학의 활용이 확대됨에 따라, 가까운 시일 내에 시장 성장이 촉진될 것으로 예상됩니다.
바이오소재는 약물전달에 널리 이용되며, 생분해성이기 때문에 그 기능을 다한 후에는 생체 내에서 사라집니다. 이들은 뼈 대체재, 정형외과 수술에서의 연골 재생, 콜라겐 막, 재생 치과 치료 등의 의료 용도로 사용될 수 있습니다. 조직공학의 발전과 무릎 및 고관절 치환술 건수의 증가는 전 세계 천연 바이오소재 시장의 성장에 유망한 기회를 제공하고 있습니다. 또한, 주요 기업들의 첨단 바이오소재 제품 개발을 위한 광범위한 연구 개발 활동 역시 시장 성장을 견인할 것으로 예상됩니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 촉진요인, 시장 억제요인, 기회, 신제품 출시 및 승인, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 주요 지표를 바탕으로 전 세계 천연 바이오소재 시장의 주요 기업 개요을 작성하였습니다 : 기업 개요, 재무 실적, 제품 포트폴리오, 사업 전개 지역, 유통 전략, 주요 발전 및 전략, 그리고 향후 계획.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 기술 업그레이드, 시장 확대 및 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 천연 바이오소재 시장 보고서는 투자자, 공급업체, 천연 바이오소재 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 천연 바이오소재 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 천연 바이오소재 시장 : 제품 유형별, 2021-2033년
제5장 세계의 천연 바이오소재 시장 : 용도별, 2021-2033년
제6장 세계의 천연 바이오소재 시장 : 지역별, 2021-2033년
제7장 경쟁 구도
제8장 섹션
KSM 26.06.19Natural Biomaterials Market is estimated to be valued at USD 86.7 Bn in 2026 and is expected to reach USD 103.3 Bn by 2033, growing at a compound annual growth rate (CAGR) of 4.8% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 86.7 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 4.80% | 2033 Value Projection: | USD 103.3 Bn |
Biomaterials are regarded as non-drug material, which is used for enhancing or replacing and treating any tissue, organ or function in an organism. The definition of biomaterial was reframed as a non-drug substance, which is suitable for inclusions in systems, replacing or augmenting the function of body tissue or organ. This materials can be synthetic or natural, non-living or living, and are made of multiple components that interact with biological system. They are compatible to be used in place of living tissues in organisms.
Market Dynamics
Increase in investment in research and development of precision medicine and molecular biology is the key factor augmenting the market. Rise in geriatric population that is prone to various chronic diseases is another factor boosting the demand for natural biomaterials. Growth in usage of biomaterial science in various advanced medical technologies, such as drug delivery devices, plastic surgery, tissue engineering, and other medical implants, is expected to propel the market growth in the near future.
Biomaterials are widely used in drug delivery and are biodegradable so that they can disappear from organism after the completion of their function. These can be used in medical applications as replacement to bones, cartilage regeneration during an orthopedic surgery, collagen membrane and regenerative dentistry. Advancements in tissue designing and increase in number of knee and hip replacement surgeries have created lucrative opportunities for the global natural biomaterials market growth. Extensive research and development activities supported by key players to develop advanced biomaterial products is also anticipated to boost the market growth.
Key features of the study
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global natural biomaterials market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
- Key companies covered as a part of this study include, BASF SE, Biomet, Inc., Invibio Ltd., Mimetis Biomaterials, Royal DSM, Corbion N.V., Botiss Biomaterials GmbH, and Medtronic, Inc.
- Insights from this report would allow marketers and management authorities of companies to make informed decision regarding future products launches, technology up gradation, market expansion, and marketing tactics
- The global natural biomaterials market report caters to various stakeholders in this industry including investors, suppliers, natural biomaterials manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global natural biomaterials market
Market Segmentation
- By Product Type (Revenue, USD Bn, 2021-2033)
- Hyaluronic Acid
- Collagen
- Gelatin
- Fibrin
- Cellulose
- Chitin/chitosan
- Others
- By Application (Revenue, USD Bn, 2021-2033)
- Cardiovascular
- Orthopedic
- Dental
- Plastic Surgery
- Wound Healing
- Neurology
- Neurological Disorders/Central Nervous Systems
- Tissue Engineering
- Ophthalmology
- Others
- By Region (Revenue, USD Bn, 2021-2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Key Players
- BASF SE
- Biomet, Inc.
- Invibio Ltd.
- Mimetis Biomaterials
- Royal DSM
- Corbion N.V.
- Botiss Biomaterials GmbH
- Medtronic, Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Application
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- PEST Analysis
- PORTER's Five Forces Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trend
4. Global Natural Biomaterials Market, By Product Type, 2021-2033 (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hyaluronic Acid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Collagen
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Gelatin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Fibrin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Cellulose
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Chitin/Chitosan
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Natural Biomaterials Market, By Application, 2021-2033 (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Cardiovascular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Orthopedic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Dental
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Plastic Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Wound Healing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Neurological Disorders/Central Nervous Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Tissue Engineering
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Ophthalmology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Natural Biomaterials Market, By Region, 2021-2033 (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2033
- North America
- Market Share Analysis, By Country, 2021-2033
- Y-o-Y Growth Analysis, By Country, 2021-2033
- Market Size and Forecast, By Product Type, 2021-2033 (USD Bn)
- Market Size and Forecast, By Application, 2021-2033 (USD Bn)
- Countries
- U.S.
- Canada
- Latin America
- Market Share Analysis, By Country, 2021-2033
- Y-o-Y Growth Analysis, By Country, 2021-2033
- Market Size and Forecast, By Product Type, 2021-2033 (USD Bn)
- Market Size and Forecast, By Application, 2021-2033 (USD Bn)
- Countries
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Market Share Analysis, By Country, 2021-2033
- Y-o-Y Growth Analysis, By Country, 2021-2033
- Market Size and Forecast, By Product Type, 2021-2033 (USD Bn)
- Market Size and Forecast, By Application, 2021-2033 (USD Bn)
- Countries
- France
- Germany
- Italy
- Spain
- U.K.
- Russia
- Rest of Europe
- Asia Pacific
- Market Share Analysis, By Country, 2021-2033
- Y-o-Y Growth Analysis, By Country, 2021-2033
- Market Size and Forecast, By Product Type, 2021-2033 (USD Bn)
- Market Size and Forecast, By Application, 2021-2033 (USD Bn)
- Countries
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East & Africa
- Market Share Analysis, By Country, 2021-2033
- Y-o-Y Growth Analysis, By Country, 2021-2033
- Market Size and Forecast, By Product Type, 2021-2033 (USD Bn)
- Market Size and Forecast, By Application, 2021-2033 (USD Bn)
- Countries
- Middle East
- Africa
7. Competitive Landscape
- Heat Map Analysis
- Market Share Analysis (3x3 Matrix)
- Company Profiles
- BASF SE
- Company Overview
- Product Portfolio
- Recent Developments/Updates
- Biomet, Inc.
- Company Overview
- Product Portfolio
- Recent Developments/Updates
- Invibio Ltd.
- Company Overview
- Product Portfolio
- Recent Developments/Updates
- Botiss Biomaterials GmbH
- Company Overview
- Product Portfolio
- Recent Developments/Updates
- Medtronic, Inc.
- Company Overview
- Product Portfolio
- Recent Developments/Updates
- Mimetis Biomaterials
- Company Overview
- Product Portfolio
- Recent Developments/Updates
- Royal DSM
- Company Overview
- Product Portfolio
- Recent Developments/Updates
- Corbion N.V.
- Company Overview
- Product Portfolio
- Recent Developments/Updates
- BASF SE
8. Section
- References
- Research Methodology
- About Us and Sales Contact
